SYNGAP1 and epilepsy: Likewise, appropriate and validated transgenic models for neurodevelopmental genes involved in epilepsy, such as MeCP2, SYNGAP1, FMR1, SHANK1-3, and TSC1, could increase our knowledge both on the pathogenic basis of epilepsy-associated ASD and the discovery of effective drugs for both disorders.